Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Income towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesResearch & DevelopmentShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intelligent Bio Solutions (INBS) Income from Continuing Operations (2019 - 2025)

Intelligent Bio Solutions has reported Income from Continuing Operations over the past 6 years, most recently at 2811717.0 for Q2 2024.

  • For Q2 2024, Income from Continuing Operations fell 4.04% year-over-year to 2811717.0; the TTM value through Jun 2024 reached 10381476.0, up 16.24%, while the annual FY2024 figure was 10283174.0, 18.29% up from the prior year.
  • Income from Continuing Operations for Q2 2024 was 2811717.0 at Intelligent Bio Solutions, up from 2985769.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 111107.0 in Q1 2020 and troughed at 6352017.0 in Q1 2023.
  • A 5-year average of 2152326.83 and a median of 2052478.0 in 2022 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 2728.5% in 2021 and later surged 57.23% in 2022.
  • Year by year, Income from Continuing Operations stood at 1990389.0 in 2020, then crashed by 74.03% to 3463823.0 in 2021, then soared by 38.52% to 2129494.0 in 2022, then rose by 5.13% to 2020316.0 in 2023, then plummeted by 39.17% to 2811717.0 in 2024.
  • Business Quant data shows Income from Continuing Operations for INBS at 2811717.0 in Q2 2024, 2985769.0 in Q1 2024, and 2020316.0 in Q4 2023.